thiotepa has been researched along with Histiocytic Sarcoma in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Histiocytic Sarcoma: Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becton, DL | 1 |
| Kurtzberg, J | 1 |
| Kinney, TR | 1 |
| Friedman, HS | 1 |
| Chaffee, S | 1 |
| Falletta, JM | 1 |
1 other study available for thiotepa and Histiocytic Sarcoma
| Article | Year |
|---|---|
Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Child, Preschool; Cyclohe | 1987 |